Please upgrade your browser.
Rates of death in the United States from all cancers for men and women continued to decline between 2003 and 2007, the most recent reporting period available, according to the latest Annual Report to the Nation on the Status of Cancer. The report also finds that the overall rate of new cancer diagnoses for men and women combined decreased an average of slightly less than 1 percent per year for the same period.
For the first time, U.S. News has ranked hospitals in America's 52 largest metropolitan areas.
Abstracts in Renal Cell Carcinoma and Trials in Progress Abstracts will be accepted for poster display at the 10th International Kidney Cancer Symposium, October 14-15, in Chicago.
An increasing number of cancer patients are using complementary and alternative medicine (CAM) without their physicians' knowledge, putting them at risk of adverse interactions with conventional medicine, according to a review published today.
According to a latest study, for patients suffering from kidney cancer, it is always better to get the damaged part of kidney removed rather than getting the entire organ, because in later cases, the patients are then more likely to have renal complications and poorer health after surgical treatment.
We present three cases of pancreatic metastases from clear renal carcinoma confirmed with 64-row MSCT and with histological confirmation of primary RCC and related metastases.
A number of new agents have been approved for systemic therapy of metastatic renal cell carcinoma (mRCC) recently. Thereby, prognostic factors may aid in predicting the effectiveness of various treatment modalities in individual cases. Aim of this study was to determine the value of human leukocyte antigen (HLA) class II characteristics in predicting response of mRCC to combined immunochemotherapy (ICT).
U.S. Patent and Trademark Office has issued patent number 7,901,879, entitled, "Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases."
|Powered by NeonCRM|